Log in
Enquire now
Stalicla

Stalicla

Stalicla is a drug development platform for neurodevelopmental disorders founded in 2017 by Lynn Durham.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Lynn Durham
CFO
‌
Laurent Forestier
Country
Switzerland
Switzerland
Crunchbase URL
crunchbase.com/organiz...stalicla
Email Address
info@stalicla.com
Founded Date
2017
Founder
‌
Lynn Durham
Headquarters
Geneva
Geneva
Industry
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
Healthcare
Healthcare
Medicine
Medicine
‌
Neurobiology
Medical diagnostics
Medical diagnostics
Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder (ASD)
Biotechnology
Biotechnology
Investors
Addex Therapeutics
Addex Therapeutics
Latest Funding Round Date
June 30, 2025
Latest Funding Round Amount (USD)
2,500,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/stalicla
Location
Geneva
Geneva
Switzerland
Switzerland
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Total Funding Amount (USD)
27,471,700
Official Website
stalicla.com

Find more companies like Stalicla

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.